Novanta
NOVT Nasdaq Electronic Equipment & Instruments Financials FY2016βFY2025
Novanta's revenue rose 3.3% to $981 million in fiscal 2025. Its operating margin was 9.6%, down from 11.7% a year earlier. Free cash flow was $48 million, down 65.7%. It paid out $39 million in dividends and buybacks, 81% of free cash flow. The diluted share count rose 1.6%.
What Novanta does
No business description yet.
- Legal name
- NOVANTA INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-064230
0001076930
Revenue and margins
Novanta had $981M of revenue in fiscal 2025, up 3.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 9.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $48.4M in fiscal 2025, 4.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Novanta returned $39.3M to shareholders in fiscal 2025, 81% of free cash flow. The diluted share count rose 1.6%.
Value Novanta yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $127M and divides by 36.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 89.7x Β· peers 33.4x Β· sector 33.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Novanta can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $117M | $100M | $105M | $114M | $381M |
| Debt incl. finance leases | $440M | $441M | $359M | $421M | $254M |
| Net debt / EBITDA | 3.0x | 2.2x | 1.6x | 1.9x | β0.8x |
| Debt / equity | 0.8x | 0.8x | 0.5x | 0.6x | 0.2x |
| Interest coverage | 10.3x | 7.2x | 4.4x | 3.4x | 4.2x |
| Current ratio | 2.0x | 2.6x | 3.0x | 2.6x | 3.7x |
| Quick ratio | 1.4x | 1.5x | 1.9x | 1.7x | 2.8x |
| Total assets | $1.2B | $1.2B | $1.2B | $1.4B | $1.8B |
| Total liabilities | $707M | $664M | $553M | $643M | $493M |
| Shareholders' equity | $521M | $578M | $674M | $746M | $1.3B |
| Net debt (β = net cash) | $323M | $341M | $254M | $307M | β$127M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$10.3M
3 insiders
Of sales under plans
100%
$10.3M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Thomas N SecorDirector | Sold plan | 663 | $147.60 | $0.1M | Form 4 |
| Jul 2, 2026 | Matthijs GlastraChief Executive Officer, Director | Sold plan | 6,500 | $161.13 | $1.0M | Form 4 |
| Jun 2, 2026 | Matthijs GlastraChief Executive Officer, Director | Sold plan | 6,500 | $168.66 | $1.1M | Form 4 |
| May 12, 2026 | Matthijs GlastraChief Executive Officer, Director | Sold plan | 7,500 | $150.43 | $1.1M | Form 4 |
| May 5, 2026 | Matthijs GlastraChief Executive Officer, Director | Sold plan | 6,500 | $131.13 | $0.9M | Form 4 |
| Apr 17, 2026 | Matthijs GlastraChief Executive Officer, Director | Sold plan | 6,500 | $130.05 | $0.8M | Form 4 |
| Mar 16, 2026 | Robert BuckleyChief Financial Officer | Sold plan | 9,957 | $116.77 | $1.2M | Form 4 |
| Mar 2, 2026 | Matthijs GlastraChief Executive Officer, Director | Sold plan | 6,500 | $138.34 | $0.9M | Form 4 |
| Feb 20, 2026 | Robert BuckleyChief Financial Officer | Sold plan | 1,423 | $140.88 | $0.2M | Form 4 |
| Feb 10, 2026 | Matthijs GlastraChief Executive Officer, Director | Sold plan | 7,500 | $145.04 | $1.1M | Form 4 |
| Feb 2, 2026 | Matthijs GlastraChief Executive Officer, Director | Sold plan | 6,500 | $135.15 | $0.9M | Form 4 |
| Jan 21, 2026 | Matthijs GlastraChief Executive Officer, Director | Sold plan | 7,500 | $140.00 | $1.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 4 / 9 | 5 / 9 |
| Accruals ratio | β3.8% | β7.2% | β0.6% |
| Altman Z'' | 3.90 | 3.64 | 5.80 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Novanta NOVT | $5.8B | 3.3% | 9.6% | 4.9% | 6.5% | 89.7x | 5 | |
| Cognex CGNX | $9.4B | 8.7% | 16.4% | 23.8% | 8.4% | 53.4x | 7 | Compare β |
| Crane NXT CXT | $3.3B | 11.4% | 14.9% | 12.0% | 10.4% | 23.6x | 4 | Compare β |
| Vontier VNT | $4.8B | 3.2% | 18.3% | 14.3% | 15.8% | 14.2x | 6 | Compare β |
| Keysight Technologies KEYS | $54.5B | 8.0% | 16.3% | 23.8% | 12.1% | 43.1x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $385M | $521M | $614M | $626M | $591M | $707M | $861M | $882M | $949M | $981M |
| Gross profit | $163M | $221M | $262M | $262M | $245M | $300M | $379M | $400M | $422M | $435M |
| Research and development | $32.0M | $41.7M | $51.0M | $56.0M | $61.0M | $72.5M | $85.8M | $91.7M | $95.5M | $95.5M |
| Operating income | $33.0M | $57.6M | $71.0M | $55.3M | $55.9M | $64.1M | $103M | $111M | $111M | $94.0M |
| Interest expense | $2.9M | $5.8M | $8.9M | $8.4M | $5.5M | $6.2M | $14.3M | $25.3M | $32.7M | $22.6M |
| Pretax income | $32.5M | $76.1M | $61.3M | $45.8M | $48.4M | $56.2M | $87.2M | $83.7M | $79.1M | $69.6M |
| Income tax | $10.5M | $13.8M | $10.2M | $5.0M | $3.9M | $5.8M | $13.1M | $10.9M | $15.0M | $15.8M |
| Net income | $22.0M | $60.1M | $49.1M | $40.8M | $44.5M | $50.3M | $74.1M | $72.9M | $64.1M | $53.8M |
| Diluted EPS | $0.63 | $1.13 | $1.43 | $1.15 | $1.25 | $1.41 | $2.06 | $2.02 | $1.77 | $1.47 |
| Diluted shares | 0.03B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $47.8M | $63.4M | $89.6M | $63.2M | $140M | $94.6M | $90.8M | $120M | $159M | $64.1M |
| Capital expenditure | $8.5M | $9.1M | $14.7M | $10.7M | $10.5M | $20.0M | $19.6M | $20.0M | $17.2M | $15.6M |
| Free cash flow | $39.3M | $54.3M | $75.0M | $52.5M | $130M | $74.7M | $71.1M | $100M | $141M | $48.4M |
| Depreciation and amortization | $21.0M | $30.8M | $37.1M | $38.3M | $38.3M | $43.4M | $53.2M | $46.6M | $55.6M | $61.9M |
| Stock-based compensation | $4.3M | $5.5M | $7.7M | $9.3M | $23.1M | $25.6M | $23.1M | $25.6M | $23.3M | $29.5M |
| Acquisitions | $9.0M | $168M | $33.5M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $1.6M | $0.4M | $5.8M | $10.0M | $5.5M | $0.0M | $10.0M | $0.0M | $0.0M | $39.3M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $1.6M | $0.4M | $5.9M | $10.0M | $5.5M | $0.0M | $10.0M | $0.0M | $0.0M | $39.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $68.1M | $100M | $82.0M | $78.9M | $125M | $117M | $100M | $105M | $114M | $381M |
| Total debt | $77.9M | $235M | $207M | $220M | $200M | $435M | $436M | $354M | $417M | $251M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $16.2M | $15.6M | $5.9M | $5.3M | $4.7M | $3.9M | $3.2M |
| Current assets | $199M | $288M | $282M | $305M | $304M | $374M | $421M | $415M | $434M | $783M |
| Current liabilities | $70.5M | $98.2M | $104M | $135M | $114M | $184M | $165M | $139M | $168M | $212M |
| Inventory | $59.7M | $91.3M | $105M | $117M | $92.7M | $126M | $168M | $149M | $145M | $188M |
| Property and equipment, net | $35.4M | $61.7M | $65.5M | $77.6M | $78.7M | $87.4M | $103M | $109M | $113M | $119M |
| Total assets | $426M | $727M | $720M | $870M | $865M | $1.2B | $1.2B | $1.2B | $1.4B | $1.8B |
| Total liabilities | $167M | $368M | $351M | $453M | $388M | $707M | $664M | $553M | $643M | $493M |
| Shareholders' equity | $259M | $312M | $368M | $417M | $477M | $521M | $578M | $674M | $746M | $1.3B |
| Margins | ||||||||||
| Gross margin | 42.2% | 42.3% | 42.6% | 41.9% | 41.4% | 42.5% | 44.0% | 45.4% | 44.4% | 44.4% |
| Operating margin | 8.6% | 11.0% | 11.6% | 8.8% | 9.5% | 9.1% | 12.0% | 12.5% | 11.7% | 9.6% |
| EBITDA margin | 14.0% | 16.9% | 17.6% | 14.9% | 16.0% | 15.2% | 18.2% | 17.8% | 17.5% | 15.9% |
| Net margin | 5.7% | 11.5% | 8.0% | 6.5% | 7.5% | 7.1% | 8.6% | 8.3% | 6.8% | 5.5% |
| FCF margin | 10.2% | 10.4% | 12.2% | 8.4% | 22.0% | 10.6% | 8.3% | 11.4% | 14.9% | 4.9% |
| Returns | ||||||||||
| Return on capital | 8.1% | 13.2% | 12.6% | 9.2% | 9.0% | 8.1% | 9.9% | 10.4% | 9.1% | 6.5% |
| Return on capital employed | 9.2% | 11.7% | 11.4% | 8.2% | 7.5% | 7.1% | 9.7% | 10.2% | 9.6% | 6.7% |
| Return on equity | 8.7% | 21.1% | 14.5% | 10.4% | 10.0% | 10.1% | 13.5% | 11.7% | 9.0% | 5.2% |
| Return on assets | 5.2% | 10.4% | 6.8% | 5.1% | 5.1% | 4.8% | 6.0% | 5.9% | 4.9% | 3.4% |
| Growth | ||||||||||
| Revenue growth | 3.0% | 35.5% | 17.9% | 1.9% | β5.7% | 19.7% | 21.8% | 2.4% | 7.7% | 3.3% |
| Net income growth | β38.2% | 172.9% | β18.2% | β17.0% | 9.2% | 13.1% | 47.1% | β1.6% | β12.1% | β16.0% |
| EPS growth | β38.2% | 79.4% | 26.6% | β19.6% | 8.7% | 12.8% | 46.1% | β1.9% | β12.4% | β17.0% |
| FCF growth | 41.1% | 38.0% | 38.1% | β30.0% | 147.1% | β42.5% | β4.7% | 40.7% | 41.2% | β65.7% |
| Share count change | 0.3% | 1.1% | 0.6% | 0.2% | 0.3% | 0.4% | 0.4% | 0.3% | 0.3% | 1.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.2x | 1.5x | 1.2x | 1.7x | 1.0x | 3.0x | 2.2x | 1.6x | 1.9x | β0.8x |
| Debt / equity | 0.3x | 0.8x | 0.6x | 0.6x | 0.5x | 0.8x | 0.8x | 0.5x | 0.6x | 0.2x |
| Interest coverage | 11.3x | 9.9x | 8.0x | 6.6x | 10.1x | 10.3x | 7.2x | 4.4x | 3.4x | 4.2x |
| Current ratio | 2.8x | 2.9x | 2.7x | 2.3x | 2.7x | 2.0x | 2.6x | 3.0x | 2.6x | 3.7x |
| Quick ratio | 2.0x | 2.0x | 1.7x | 1.4x | 1.9x | 1.4x | 1.5x | 1.9x | 1.7x | 2.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.2% | 1.7% | 2.4% | 1.7% | 1.8% | 2.8% | 2.3% | 2.3% | 1.8% | 1.6% |
| Stock comp / revenue | 1.1% | 1.1% | 1.3% | 1.5% | 3.9% | 3.6% | 2.7% | 2.9% | 2.5% | 3.0% |
| Payouts / FCF | 4.2% | 0.7% | 7.8% | 19.1% | 4.2% | 0.0% | 14.1% | 0.0% | 0.0% | 81.1% |
| Quality scores | ||||||||||
| Piotroski F-score | 4.0 | 7.0 | 5.0 | 5.0 | 5.0 | 6.0 | 7.0 | 7.0 | 4.0 | 5.0 |
| Altman Z'' | 2.9 | 2.6 | 3.0 | 2.5 | 3.2 | 2.3 | 3.2 | 3.9 | 3.6 | 5.8 |
| Accruals ratio | β6.1% | β0.6% | β5.6% | β2.8% | β11.0% | β4.2% | β1.4% | β3.8% | β7.2% | β0.6% |
Source: SEC EDGAR XBRL filings (CIK 0001076930). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.